ONC BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 99% planned / 1% discretionary
Largest single sale: $5.3M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Ball Titus B. 2 fills | Principal Accounting Officer | Sell | 1,559 | $405.57 | $632.3K | 26 −98.4% of holding | |
| Lee Chan Henry 2 fills | SVP, General Counsel | Sell 10b5-1 | 1,115 | $400.82 | $446.9K | 455 −71% of holding | |
| Wang Xiaodong 11 fills | Director | Sell 10b5-1 | 31,028 | $362.97 | $11.3M | 30,148 −50.7% of holding | |
| Wang Xiaodong 5 fills | Director | Sell 10b5-1 | 31,027 | $350.99 | $10.9M | 23,860 −56.5% of holding | |
| Wang Xiaodong 10 fills | Director | Sell 10b5-1 | 31,028 | $364.79 | $11.3M | 30,868 −50.1% of holding | |
| Wang Xiaodong 8 fills | Director | Sell 10b5-1 | 38,287 | $349.10 | $13.4M | 23,535 −61.9% of holding | |
| Ball Titus B. | Principal Accounting Officer | Sell | 132 | $355.86 | $47.0K | None left | |
| Wu Xiaobin | President and COO | Sell 10b5-1 | 280 | $380.00 | $106.4K | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.